NCT04620239

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

← 임상시험 허브

레지스트리 요약

진행 상태: 완료 (COMPLETED)
질환/조건: Transitional Cell Cancer of Renal Pelvis and Ureter
시험 유형: 중재 연구 (INTERVENTIONAL)
단계: Phase 3
목적: 치료
중재 유형: 약물
개입·치료: padeliporfin VTP
Lead Sponsor: Steba Biotech S.A. (기타)

캐시 시각: 2026-07-21 21:31:12

ClinicalTrials.gov에서 보기

요약

This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade non-invasive upper tract urothelial carcinoma in either the kidney or the ureter. Patients will be treated with padeliporfin VTP in two phases: an Induction Treatment Phase and a Maintenance Treatment Phase and will be followed up for up to an additional 48 months in the long term (non intervention) follow up phase with the specific duration depending on the patient's response to treatment

문의

이 시험 기반 리포트·메디컬라이팅이 필요하시면 문의해 주세요.

리포트 문의 메디컬라이팅 문의 맞춤 리서치 리포트